Drug Profile
Lamivudine/nevirapine/stavudine - Macleods Pharmaceuticals
Alternative Names: Nevirapine/lamivudine/stavudine - Macleods Pharmaceuticals; Nevirapine/stavudine/lamivudine - Macleods Pharmaceuticals; Stavudine/lamivudine/nevirapine - Macleods Pharmaceuticals; Stavudine/nevirapine/lamivudine - Macleods PharmaceuticalsLatest Information Update: 26 Nov 2018
Price :
$50
*
At a glance
- Originator Macleods Pharmaceuticals
- Class 3-ring heterocyclic compounds; Antiretrovirals; Azepines; Cyclopropanes; Deoxyribonucleosides; Dideoxynucleosides; Nucleosides; Pyridines; Pyrimidine nucleosides; Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed HIV-1 infections